October 9, 2002Features
The tactics have changed, sometimes dramatically, but hints of the promise of pharmacogenomics are finally starting to trickle in from studies of asthma, cancer, and drug response.
By Malorye A. Branca
An explosion of structural information is on the horizon, and the Protein Data Bank—the single international repository for data on the three-dimensional structures of biomolecules—is ready.
By Tracy Smith Schmidt
Scientists have demonstrated that DNA computers can solve complex problems, but the verdict is out on whether they will ever become practical.
By Salvatore Salamone News·Analysis Lab Instruments Come Online at LastReading, Writing, and BioinformaticsRNAi Fever Heats Up Novel Drug Category FundingUnleashing the Alpha YeastFDA Gives Biologics a New LookNew Pharma Cantata Sprouts from CereonABI Building the Amazon.com of BiologyISB Group Releases New Proteomics SoftwareMixed Storage Made SimplerHorizonsINNOVATION Apple seems to be winning support from life science IT staffs. CONVERSATION John Dodge speaks with Dell about his company’s foray into the life sciences. GUEST COMMENTARY The high-throughput drug discovery field requires an optimal IT platform. CONVERSATION AnVil's founder talks to Mark D. Uehling about the future of data visualization. Columns & Departments
| Kevin Davies
The 'Druggable Genome'
| Debra Goldfarb · IDCA Study in Contrasts
| Kevin DaviesAffairs of the Heart
ANALYSIS The Appliance of Sequence · Etrials Fine-Tunes EDC Tool · Tripos Ports Software Pair to New Platforms · TurboGenomics Offers TurboBench 2.0
| John Dodge
Dell Not "Buffaloed" by Bioinformatics